Thursday, January 05, 2017 5:00:55 PM
I also listened in on the conference call though I missed the first 5 minutes or so and I have to say the analysts who asked questions at the end should be shot. They all harped on technical info that the company didn't have answers to yet and in the end if Macrilen is a failure who gives a rats ass about. I mean I guess if I was going to be tested for AGHD it would matter. And it didn't seem to fail by a lot but fail is fail. So for now, All I really cared about is What happens to the company going forward if Zoptrex fails? Do they go out of business? I mean they don't have much else in the pipe line as I see it, and the two drugs/tests they have know don't seem to be generating much income, so how will they survive if they had to borrow money to pin there hopes on Zoptrex. So cash flow will be a paramount concern.
In the end if Z some how manages to pass we are all going to be happy, but losing the cushion IMO that would have sustained stock price and the company puts us and them in a seemingly perilous position.
I think I need to see the company find another customer for Zoptrex, in the next two weeks, to make me feel that this new customer wants in before the price goes up, to make me feel more confident about it or just some positive news at least. Not just silence. Silence is not golden.
Just my opinion anyway.
Balls of steel or brains of mush----??????????
Recent CSCI News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 11:30:23 AM
- COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs • GlobeNewswire Inc. • 09/23/2024 11:30:00 AM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 09/06/2024 06:04:41 PM
- COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency • GlobeNewswire Inc. • 08/27/2024 11:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 12:05:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 12:05:17 PM
- COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 12:05:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM